Skip to main content
VulnerabilityPublished

CVE-2026-24216: NVIDIA BioNeMo Framework · Deserialization of Untrusted Data

Affects NVIDIA BioNeMo FrameworkSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 7.8 High : upgrade to commit dfd83a7 in Main soon.

Data as of 21 Nov 2026, 17:35 UTC

CVSS 3.1 base score
7.8High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 21% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in commit dfd83a7 in Main
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 20 May 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 21 Nov 2026.

What to do

Upgrade NVIDIA BioNeMo Framework to commit dfd83a7 in Main.

Affected software

ProductAffectedFixed in
NVIDIABioNeMo FrameworkAffected
  • =0
Fixed in
  • commit dfd83a7 in Main

AI-suggested

If you cannot patch yet, users should limit local access to trusted users and avoid processing untrusted serialized data with the BioNeMo Framework.

Description

CVE-2026-24216 is a high-severity vulnerability in the NVIDIA BioNeMo Framework for Linux involving deserialization of untrusted data. Exploitation could allow an attacker to execute code, cause denial of service, disclose information, or tamper with data. The vulnerability requires local access with low complexity and user interaction.

References

Community reviews

Loading reviews…